Cite
MLA Citation
Mahamat Babagana et al.. “The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies.” Molecular carcinogenesis, vol. 59, no. 1, 2020, pp. 5–14. http://access.bl.uk/ark:/81055/vdc_100158310544.0x00002a